Dr. Supratik Bhattacharyya is a globally trained endocrinologist and diabetologist with extensive international exposure and leadership in diabetes and obesity care. He is the Director of a Centre of Excellence in Diabetes & Endocrinology and a Senior Consultant at Manipal Hospitals Broadway, Kolkata. Known for his evidence-based, patient-centric approach, he actively contributes to global research, education, and clinical innovation in endocrinology.

Educational Qualification

• MBBS (with Distinction)
• MRCP – United Kingdom
• MD – General Medicine
• MS – Endocrinology & Diabetes, London
• FRCP – Royal College of Physicians, Edinburgh
• FACE – American Association of Clinical Endocrinology
• FACP – American College of Physicians
• FRSSDI – Research Society for the Study of Diabetes in India
• SCOPE Certification – Obesity Management
• Executive Management Programs – Darden (University of Virginia) & IIM Ahmedabad

Professional Experience

• Senior Consultant – Diabetes & Endocrinology, Manipal Hospitals Broadway, Kolkata
• Director – SKN Diabetes & Endocrine Centre (Centre of Excellence)
• Former Assistant Professor – Medical Education Services, West Bengal
• Visiting Lecturer – Endocrinology & Diabetes, University of South Wales, UK (2018–2019)
• Principal Investigator / Co-Investigator – Multiple Phase 3 & Phase 4 Clinical Trials

Awards & Achievements

• Inspiring Endocrinologist & Diabetologist of India Award – Economic Times (2022)
• International Rising Star Award – International Diabetes Center, Park Nicollet (2021)
• Rising Star Award (Endocrinology & Diabetes) – Indian Academy of Diabetes (2021)
• RSSDI Award for Best Innovation in Diabetes Care (2020)
• Best Oral Paper Presentation – Asia Pacific Congress of Hypertension (2021)
• ACP Governor’s Recognition Award (2021)
• Best National Diabetes Awareness Initiative Award – Diabetes India (2016)
• National Scholar & Academic Distinction Holder
• Gold Certificate Holder – A-level Exam (UK)
• Distinction Holder in Medical School & Post Graduation

Professional Membership

• Fellow – Royal College of Physicians (Edinburgh)
• Fellow – American Association of Clinical Endocrinology (AACE)
• Fellow – American College of Physicians (ACP)
• Member – Research Society for the Study of Diabetes in India (RSSDI)
• Member – Diabetes India
• Member – Indian Society of Hypertension

Fellowship

• FRCP (Edinburgh)
• FACE (USA)
• FACP (USA)

Publications

• SOLID Study, ADA poster presentation 2024
• A Single Center Cross-sectional Study of Body Composition in Newly Diagnosed T2DM Patients, AACE poster 2022
• Efficacy and Safety of Liraglutide in Indian Adolescents with T2DM & Obesity, ATTD poster 2022
• Efficacy & Safety of Empagliflozin + Linagliptin in Non-hospitalized COVID-19 Positive T2DM Patients, Endocrine Practice 2021
• Once-Daily Fixed-Ratio Coformulation of Degludec-Aspart + Empa-Lina FDC in Post-COVID T2DM Patients, Diabetes June 2021
• Clinical Effectiveness of Dulaglutide Monotherapy in Obese Indian Adults with Prediabetes, EndocrPract. 2019
• Safety & Efficacy of Faster Acting Insulin Aspart in T2DM with CKD, EndocrPract. 2020
• Real-World Effectiveness of Empagliflozin + Linagliptin Combination (Empa/Lina) in Indian T2D Subjects, EndocrPract. 2020
• Combination Therapy with Dulaglutide, SGLT2 inhibitor, and Metformin ± Insulin in Indian Adults with T2DM, Clinical Diabetology 2020
• Saroglitazar & its Impact on Diabetic Dyslipidemia, Indian Journal of Basic & Applied Medical Research 2018
• Insulin Degludec/Liraglutide Fixed-Ratio Combination in OAD Failure T2DM Patients, Int J Diab 2020
• Evaluation of Blood Lipid Parameters & Correlation with HbA1c, Indian Journal of Basic & Applied Medical Research 2017
• Comparison of Basal-Bolus vs Oral Hypoglycemic Regimens in T2DM, Int J Pharm Biol Chem Sci 2015
• Medical Nutrition Therapy in Diabetes Management, Research & Reviews: Journal of Medical & Health Sciences 2019
• Adaptation of IDF-DAR Guidance in Ramadan Fasting, Proceedings of IDF Congress 2019

Editorial & Reviewer Roles

• International Editor, Bangladesh Journal of Endocrinology and Metabolism (BJEM)
• Reviewer, Endocrine Practice Journal of AACE

Book Chapters

• Aligning Therapeutic Options with Management Goals in Elderly Patients with Diabetes, RSSDI Diabetes Update 2019
• DCCT & UKPDS, RSSDI Diabetes Update 2020

Invited Speaker / Conferences

• RSSDI Research Retreat 2022
• RSSDI Gujarat Chapter 2022
• Dialogues in Diabetes
• International Diabetes Summit 2022 (CDI)
• ENDODIALOGUE 2022
• DIABETES INDIA 2022
• DTechCON 2022
• International Nutritional Summit 2022
• ADA PRIMER 2021
• International Diabetes Summit 2021 (Chellaram Diabetes Institute)
• IM ACP 2021
• RSSDI 2021
• Mid-term AIIROCON, DI 2021
• ADC International Virtual Global Summit 2021
• National RSSDI 2020
• DiaCON 2020
• UPDACON 2020
• E-Diabcon 2020, Delhi
• Dr. Mohan’s International Diabetes Update (DMIDU) 2020
• DiaVcon 2020 (Indian Academy of Diabetes)
• Diabetes India 2020
• DIYA International Meeting, Busan, South Korea 2019
• Diabetes SUMMIT, Singapore 2019
• RSSDI, Jaipur 2019
• Indian Academy of Diabetes & MEND (Mayo Clinic) Update 2019
• Master Course in Diabetes Clinical Management, Diploma MSc (UK), Kolkata 2018
• Diabetes India 2018
• Dr. Mohan’s International Diabetes Update, Chennai 2018
• DIAMONDS (Diabetes update) Programme, Paris 2017
• Indian Medical Association (Multiple venues, Kolkata) 2017
• Insulin Discovery Day (IDA) 2016
• Diabetes Summit, Bangkok 2016
• Basal Insulin Summit 2016
• World Diabetes Day (RSSDI) 2015

National / International Advisory Roles

• May 2022: eConsultancy Generic DAPA – Advisory on DapaVilda FDC
• April 2022: Medical Nutritional Formulation Advisory

Teaching, Academics & Research

• Former Assistant Professor, Medical Education Services, WB
• Visiting Lecturer, Endocrinology & Diabetes, University of South Wales, UK (2018-2019)
• Speaker, Moderator, Chairperson – Various National/International CMEs & Webinars
• SCOPE (Obesity) Certified & Preceptorship in Obesity Management, Guys & St. Thomas (London), NHS, UK
• Principal Investigator / Co-Investigator – Multiple Phase 3 & Phase 4 Studies, including International DIARAMADAN study